Federal Supply Schedule V797D50516

The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Altitude Technologies Inc., doing business as Chinook Medical Gear. The contract is valued at $225,000.00 and has an ultimate completion date of January 31, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS contract category 65 I B. Chinook Medical Gear is an 8(a)...

This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs, to IBSA Pharma Inc., a foreign-owned for-profit organization. The contract is for the delivery of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65-IB. The contract has a ceiling value of $1,020,000.00 and a period of performance through July 31, 2025. As a Federal Supply Schedule contract,...

The federal contract IDV award is for the procurement of influenza virus vaccines for the 2024-2025 flu season. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. This award is being made by the U.S. Department of Veterans Affairs (VA) National Acquisition Center and will be used to supply vaccines to the VA, State Veteran Homes, Bureau of Prisons, Indian Health Service, and Captain James A. Lovell Federal Health Care Center. The...

The Department of Veterans Affairs Veterans Health Administration awarded a multiple-award Federal Supply Schedule contract to Biocon Biologics Inc., a foreign-owned, for-profit manufacturer of goods. The contract provides an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The potential value of the contract is $25 million. Delivery orders may be placed under the contract through February 2029. The contract facilitates procurement of...

This federal contract indefinite delivery vehicle (IDV) is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Cipla USA Inc., a foreign-owned, for-profit pharmaceutical company. The contract is under the GSA's Pharmaceuticals and Drugs Schedule (FSS-61-IB) and has a period of performance through February 2026, with a $225,000 ceiling value. The contract provides for the delivery of a wide range of pharmaceutical and hematology-related products...

The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc., for the supply of Bupropion Hydrochloride (HCL) Tablets in 100mg and 75mg dosages. The contract, valued at $2,936,792.25, has a base period of performance from March 1, 2025, to February 28, 2026, with four one-year option periods. The contracted items will be distributed through the VA's and...

This Blanket Purchase Agreement (BPA) contract was awarded by the National Acquisition Center, a civilian federal agency, to Ipsen Biopharmaceuticals Inc. The contract has a ceiling value of $535,300.00 and a period of performance through April 2, 2026. The BPA is for the procurement of SOHONOS, a pharmaceutical product. It was awarded under the General Services Administration (GSA) Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. The contract does not utilize any set-asides and...

This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Fera Pharmaceuticals, LLC, a woman-owned small business. The BPA, valued at up to $255,000, is for the procurement of Phospholine Iodide, a pharmaceutical drug. The BPA was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and allows the VA and other agencies to efficiently and compliantly acquire the needed pharmaceutical product from Fera...

This federal contract IDV award is for the supply of ranibizumab ophthalmic injections to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award indefinite delivery contract, valued at $11,392,063.40, was issued by the VA National Acquisition Center to the prime contractor Biogen U.S. Corporation, a for-profit pharmaceutical manufacturer. The contract has a performance period from December 23, 2023, through December 22, 2025, with four...

This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, provides for the delivery of pharmaceuticals, drugs, and hematology-related products. The $24,000,000 multiple-award contract has a period of performance through August 31, 2026. The prime contractor is Biodelivery Sciences International, Inc., a for-profit manufacturer of goods. Biodelivery Sciences' parent company is Collegium Pharmaceutical Inc....